REG - BSF Enterprise PLC - Publication of Prospectus & Notice of GM

BSF EnterpriseAnnouncement

07/09/2023 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230907:nRSG7218La&default-theme=true

RNS Number : 7218L  BSF Enterprise PLC  07 September 2023

RNS Number: 5566J

BSF Enterprise PLC

7 September 2023

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR
CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY
PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ANY
JURISDICTION.

 

7 September 2023

BSF Enterprise PLC

Publication of Prospectus

Notice of General Meeting

BSF Enterprise Plc (LSE: BSFA) (OTCQB: BSFAF) (the "Company"), the Main Market
listed biotech company and owner of pioneering UK-based clinical and cellular
agriculture company 3D Bio-Tissues, is pleased to announce that, further to
the conditional fundraising announced on 29 March 2023, 12 April 2023 and 14
April 2023 ("Previous Announcements"), the Company has today received approval
from the Financial Conduct Authority (the "FCA") of its prospectus (the
"Prospectus") relating to the proposed issuance (the "Share Issue") of up to
29,542,200 new ordinary shares ("Ordinary Shares") and has published its
Prospectus.

 

The Share Issue relates primarily to the future warrants (Placing Warrants,
Subscription Warrants and Broker Warrants at a price of 34 pence per share)
that were part of the £2.9 million fundraise in March this year.

 

As described in the Previous Announcements, the Company raised approximately
£2.9 million by way of Fundraising, comprising the Placing of 16,317,648
Placing Shares and the Subscription of 882,352 Subscription Shares at a price
of 17 pence per share.

 

The Subscription was structured in two tranches. The first tranche consisting
of 617,613 Ordinary Shares were allotted and issued pursuant to the then
Company's existing authorities, in addition to the Placing Shares, and were
admitted to the standard segment of the Official List of the FCA and to
trading on the Main Market of the London Stock Exchange on 14 April 2023.

 

The second tranche of Subscription consisting of 264,739 Ordinary Shares,
together with the 100,000 Financial PR Shares to be issued to Roast PR in
satisfaction of certain fees due for services rendered at a price of 17 pence
per share, will be allotted and issued subject to the passing of resolutions
at the general meeting.

A notice of general meeting (the "Notice of GM") is being posted today to
shareholders where the Board recommends shareholders to vote in favour of the
resolutions. The Company will convene the general meeting at 10:00 a.m. on 26
September 2023 at the offices of Crowe U.K. LLP, 55 Ludgate Hill, London, EC4M
7JW, to consider and approve, among other matters, the allotment of shares and
disapplication of pre-emption rights in relation to the Share Issue.

 

An electronic copy of the Prospectus and Notice of GM are available for
inspection on the Company's website at www.bsfenterprise.com
(http://www.bsfenterprise.com) . The Prospectus will also be available for
inspection at the National Storage Mechanism at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

It is expected that admission of the new Ordinary Shares will become effective
at or around 8.00 a.m. on 27 September 2023 and that dealings in the new
Ordinary Shares will commence at that time. The new Ordinary Shares will, when
issued, be credited as fully paid and will rank pari passu in all respects
with the existing Ordinary Shares of the Company and will on issue be free of
all claims, liens, charges, encumbrances and equities.

Further announcements will be made in due course, as appropriate.

Terms used in this announcement shall, unless the context otherwise requires,
be as defined in the Prospectus published by the Company on 7 September 2023
in relation to the Share Issue.

For further enquiries, please visit www.bsfenterprise.com
(http://www.bsfenterprise.com/)  or contact:

 BSF Enterprise PLC                       Via SEC Newgate below
 Geoff Baker - Executive Director

 Che Connon - CEO & Director

 Shard Capital (Broker)
 Damon Heath                              020 7186 9900

 Isabella Pierre                          0207 186 9927

 SEC Newgate (Financial Communications)
 Bob Huxford                              020 3757 6882

 Elisabeth Cowell                         BSF@secnewgate.co.uk

 George Esmond

 

ISIN of the Ordinary Shares is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAPNXELADEEA